CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 51,509	$ 54,721
Grant receivables	2,794	1,799
Prepaid expenses and other current assets	2,137	2,005
Other receivables		467
Total current assets	56,440	58,992
Property and equipment, net	261	145
Right-of-use assets, operating leases	578
Other assets	1,417
Total assets	58,696	59,137
Current liabilities
Accounts payable	3,997	4,168
Accrued expenses	1,383	1,751
Deferred grant income, current	1,316	753
Operating lease liabilities, current	150
Other current liabilities	799	1,192
Total current liabilities	7,645	7,864
Operating lease liabilities, noncurrent	446
Deferred grant income and other liabilities, noncurrent	1,865
Total liabilities	9,956	7,864
Commitments and contingencies (Note 6)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at March 31, 2022 and December 31, 2021
Common stock, $0.001 par value, 250,000,000 shares authorized; 22,578,584 and 22,230,032 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	22	22
Additional paid-in capital	146,757	145,453
Accumulated deficit	(97,842)	(94,004)
Accumulated other comprehensive loss	(197)	(198)
Total stockholders' equity	48,740	51,273
Total liabilities and stockholders' equity	$ 58,696	$ 59,137

The amount of current portion of deferred grant income as at the end of the reporting period.

No definition available.

Name:	cgtx_DeferredGrantIncomeCurrent
Namespace Prefix:	cgtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).